S Amigorena

Author PubWeight™ 74.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 1998 6.36
2 Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 2001 6.32
3 Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 2001 5.71
4 Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 1999 5.55
5 Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol 1999 4.87
6 Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat Cell Biol 1999 4.53
7 FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 2002 2.31
8 TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol 1999 2.05
9 Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc Natl Acad Sci U S A 1998 1.74
10 The cell biology of antigen presentation in dendritic cells. Curr Opin Immunol 2001 1.63
11 Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: the Chediak-Higashi syndrome. J Cell Biol 1998 1.60
12 The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J Exp Med 1994 1.59
13 Tumor-derived exosomes: a new source of tumor rejection antigens. Vaccine 2002 1.33
14 Ii chain controls the transport of major histocompatibility complex class II molecules to and from lysosomes. J Cell Biol 1997 1.30
15 Structural bases of Fc gamma receptor functions. Immunol Rev 1992 1.23
16 Role of associated gamma-chain in tyrosine kinase activation via murine Fc gamma RIII. EMBO J 1992 1.20
17 syk protein tyrosine kinase regulates Fc receptor gamma-chain-mediated transport to lysosomes. EMBO J 1998 1.19
18 Vimentin filaments in fibroblasts are a reservoir for SNAP23, a component of the membrane fusion machinery. Mol Biol Cell 2000 1.15
19 A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. EMBO J 1998 1.13
20 HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments. Immunity 1996 1.09
21 The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens. J Immunol 2000 1.07
22 Induction of tolerance by exosomes and short-term immunosuppression in a fully MHC-mismatched rat cardiac allograft model. Am J Transplant 2006 1.07
23 Paucity of functional T-cell memory to melanoma antigens in healthy donors and melanoma patients. Clin Cancer Res 2000 1.00
24 Cross-linking of IgG receptors inhibits membrane immunoglobulin-stimulated calcium influx in B lymphocytes. J Cell Biol 1993 0.98
25 Antigen traffic pathways in dendritic cells. Traffic 2000 0.96
26 Dendritic cells or their exosomes are effective biotherapies of cancer. Eur J Cancer 1999 0.94
27 Milk fat globule--epidermal growth factor--factor VIII (MFGE8)/lactadherin promotes bladder tumor development. Oncogene 2010 0.92
28 Phagocytosis and antigen presentation. Semin Immunol 2001 0.91
29 The isotypic circuit: immunoglobulins, Fc receptors and immunoglobulin binding factors. Int Rev Immunol 1987 0.89
30 Regulatory effects of IgG-BF on hybridoma B cells. molecular characterization of variant cell lines. Mol Immunol 1988 0.89
31 Lonely MHC molecules seeking immunogenic peptides for meaningful relationships. Curr Opin Cell Biol 1995 0.88
32 Early endosomes are required for major histocompatiblity complex class II transport to peptide-loading compartments. Mol Biol Cell 1999 0.85
33 Exosomes in cancer immunotherapy: preclinical data. Adv Exp Med Biol 2001 0.84
34 MHC class II transport from lysosomal compartments to the cell surface is determined by stable peptide binding, but not by the cytosolic domains of the alpha- and beta-chains. J Immunol 1998 0.83
35 Methylation in the 5' region of the murine beta Fc gamma R gene regulates the expression of Fc gamma receptor II. J Immunol 1988 0.82
36 Murine low-affinity receptors for the Fc portion of IgG. Roles in cell activation and ligand internalization. Receptors Channels 1993 0.82
37 Unmethylation of specific sites in the 5' region is critical for the expression of murine alpha Fc gamma R gene. J Immunol 1990 0.79
38 Software for the quantitative evaluation of in vitro monoclonal antibody production from ELISA data. J Immunol Methods 1987 0.78
39 Bases for an isotypic network. Mol Immunol 1986 0.78
40 Intracellular signaling and endosomal trafficking of immunoreceptors. Shared effectors underlying MHC class II-restricted antigen presentation. Immunol Lett 1997 0.78
41 Molecular heterogeneity of murine IgG-BF. Mol Immunol 1986 0.77
42 Immunoglobulin G-binding factors (IgG-BF) inhibit IgG secretion by, as well as proliferation of, hybridoma B cells. Immunol Lett 1987 0.77
43 Murine soluble Fc gamma receptors/IgG-binding factors (IgG-BF): analysis of the relation to Fc gamma RII and production of milligram quantities of biologically active recombinant IgG-BF. Immunol Res 1992 0.77
44 Deficient antigen processing of a protein quaternary structure can be overcome by receptor-mediated uptake. Eur J Immunol 1993 0.75
45 In vitro inhibition of tumor B cell growth by IgG-BF-producing Fc gamma RII+ T cell hybridoma and by immunoglobulin G-binding factors. Immunol Res 1992 0.75
46 A sensitive method for testing the effect of immunoglobulin binding factor on Ig secretion by hybridoma B cells. J Immunol Methods 1987 0.75
47 Regulation of hybridoma B-cell proliferation by immunoglobulin-binding factor. Cancer Detect Prev 1988 0.75
48 21.1.1, a novel activation marker of T and B cells. Mol Immunol 1991 0.75
49 Control of B cell function by Fc gamma receptor-positive T cells and immunoglobulin-binding factors. Contrib Microbiol Immunol 1989 0.75